Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, today announced its results for the ...
The Company announces that on 6 November 2026 it bought back 10,000 of its own shares under the long-term buyback programme, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results